|
|
News Breaks
|
November 6, 2009
|
| 08:22 EDT |  | CELG |
| theflyonthewall.com: | Citigroup's Biotech Analyst to host an Analyst/Industry conference call | | Biotech Analyst Werber discusses the opportunity in Japan, Canada, Australia and the U.K. for Celgene's (CELG) Revlimid, which while offering only incremental revenues in the refractory multiple Myeloma setting, it is believed the increased duration and movement to first line usage in the future make these markets fairly attractive. The Analyst/Industry-Biotech conference call will be held on November 6 at 10 am hosted by Citigroup. :theflyonthewall.com |
|
|
News For CELG From The Last 14 Days Check below for free stories on CELG the last two weeks.
There are 5 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 10, 2012
|
| 10:01 EDT |  | CELG |
| | 06:36 EDT |  | CELG |
|
|
February 9, 2012
|
| 08:10 EDT |  | CELG |
|
|
February 6, 2012
|
| 13:00 EDT |  | CELG |
|
|
January 31, 2012
|
| 11:21 EDT | | CELG |
|
|
|
|
|
Subscribe for More Information